BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 24962384)

  • 1. Applications of structure-based design to antibacterial drug discovery.
    Cain R; Narramore S; McPhillie M; Simmons K; Fishwick CW
    Bioorg Chem; 2014 Aug; 55():69-76. PubMed ID: 24962384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.
    Gatadi S; Lakshmi TV; Nanduri S
    Eur J Med Chem; 2019 May; 170():157-172. PubMed ID: 30884322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 5. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
    Matzner D; Mayer G
    J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial drug discovery and structure-based design.
    Barker JJ
    Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confronting the challenges of discovery of novel antibacterial agents.
    Singh SB
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3683-9. PubMed ID: 25017034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where will new antibiotics come from?
    Walsh C
    Nat Rev Microbiol; 2003 Oct; 1(1):65-70. PubMed ID: 15040181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based discovery of antibacterial drugs.
    Simmons KJ; Chopra I; Fishwick CW
    Nat Rev Microbiol; 2010 Jul; 8(7):501-10. PubMed ID: 20551974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional screening approaches for antibiotic discovery.
    Farha MA; Brown ED
    Ann N Y Acad Sci; 2015 Sep; 1354():54-66. PubMed ID: 26100135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.